Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06222320Phase 3Completed
Phase 3, randomised, open-label trial (2 arms), sponsored by Kastamonu University. Primary endpoint: Visual Analogue Scale Pain Score at Day 4. Started Jan 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06222320.